D. E. Shaw & Co., Inc. Immunic, Inc. Transaction History

D. E. Shaw & Co., Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$1.14 - $1.53 $59,593 - $79,980	52,275 New	52,275 $69,000
Q3 2022 Nov 14, 2022	BUY	$3.0 - $5.49 $18,852 - $34,499	6,284 Added 12.4%	56,977 $180,000
Q2 2022 Aug 15, 2022	SELL	$3.13 - $12.25 $47,363 - $185,367	-15,132 Reduced 22.99%	50,693 $176,000
Q1 2022 May 16, 2022	BUY	$9.54 - $14.26 $627,970 - $938,664	65,825 New	65,825 $744,000

56M

4.7K

311K

Ticker IMUX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,565,000
Market Cap $36.1M
Description
Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and oth...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.